KEY PATTERNS OF HBX AND PRE-S1/S2 MUTATIONS ARE INVOLVED IN MECHANISMS UNDERLYING HBV-INDUCED HEPATOCELLULAR CARCINOMA IN VIVO
2012-01-01 Svicher, V; Mirabelli, C; Cento, V; Salpini, R; Di Maio, Vc; Bertoli, A; Alteri, C; Pollicita, M; Gori, C; Micheli, V; Salso, A; Gubertini, G; Trimoulet, P; Fleury, H; Vecchiet, J; Iapadre, N; Barlattani, A; Mari, T; Pasquazzi, C; Sarrechia, C; Ceccherini-Silberstein, F; Andreoni, M; Angelico, M; Perno, Cf
IN THE ERA OF NEW DIRECT ACTING ANTIVIRAL AGENTS HCV SEQUENCING ALLOWS THE MOST ACCURATE SUBTYPE AND GENOTYPE ASSIGNMENT
2016-01-01 Aragri, M; Di Maio, Vc; Di Paolo, D; Cento, V; De Leonardis, F; Gianserra, L; Tontodonati, M; Micheli, V; Landonio, S; Manunta, A; Bertoli, A; Ciotti, M; Antonucci, Fp; Lenci, I; Francioso, S; Nicolini, La; Marenco, S; Teti, E; Lambiase, L; Milana, M; Maida, I; Di Biagio, A; Pellicelli, A; Nosotti, L; Grieco, S; Cacciatore, P; Romagnoli, D; Siciliano, M; D'Ettorre, G; Babudieri, S; Lichtner, M; Gentilucci, Uv; Romano, M; Sarrecchia, C; Grieco, A; Morisco, F; Mastroianni, C; Vecchiet, J; Puoti, M; D'Amico, E; Gasbarrini, A; Bruno, S; Magni, C; Mura, Ms; Taliani, G; Picciotto, A; Rizzardini, G; Andreoni, M; Pasquazzi, C; Parruti, G; Angelico, M; Perno, Cf; Silberstein, Fc
LOW BURDEN OF DRUG-RESISTANT HBV STRAINS IN ANTI-HBV DRUG-EXPERIENCED AND NAIVE PATIENTS
2011-01-01 Salpini, R; Cento, V; Scopelliti, F; Bertoli, A; Gori, C; Micheli, V; Gubertini, G; De Sanctis, Gm; Sarrecchia, C; Andreoni, M; Angelico, M; Svicher, V; Perno, Cf
OVERLAPPING STRUCTURE OF HBV GENOME AND IMMUNE SELECTING PRESSURE ARE THE MAIN DRIVING FORCES FOR HBV EVOLUTION
2011-01-01 Cento, V; Mirabelli, C; Salpini, R; Han, Y; Mercurio, F; Dimonte, S; Beggel, B; Wittkop, L; Fraune, M; Gori, C; Bertoli, A; Micheli, V; Gubertini, G; Longo, R; Romano, S; Visca, M; Gallinaro, V; Marino, N; Mazzotta, F; De Sanctis, Gm; Tremulet, P; Angelico, M; Zhang, Xx; Verheyen, J; Silberstein, Fc; Perno, Cf; Svicher, V
Novel patterns of mutations in HBV reverse transcriptase associated with lamivudine resistance in HBV-HIV-coinfected patients
2009-01-01 Svicher, V; Alteri, C; Cento, V; Gori, C; Salpini, R; Marcuccilli, F; Bertoli, A; Arlotti, M; Puoti, M; Ladisa, N; Rizzardini, G; Ceccherini-Silberstein, F; Monforte, Ad; Perno, Cf
NS3 and NS5A genotypes variants correlate with slow or fast progression of HCV-related disease after liver transplantation: does the viral diversity play really a role on fibrosis progression?
2012-01-01 Lenci, I; Cucchiarelli, S; Di Maio, C; Cento, V; Milano, M; Di Paolo, D; De Luca, F; Tisone, G; Angelico, M; Perno, Cf; Ceccherini-Silberstein, F
CLINICAL RELEVANCE OF NEXT GENERATION SEQUENCING ON BASELINE DETECTION OF MINORITY RESISTANCE ASSOCIATED VARIANTS IN HCV-1 PATIENTS TREATED WITH PROTEASE INHIBITORS
2015-01-01 Armenia, D; Carioti, L; Di Maio, Vc; Bellocchi, Mc; Di Paolo, D; Guerrieri, F; Calvo, L; Cento, V; Tontodonati, M; Micheli, V; De Leonardis, F; Aragri, M; Polilli, E; Manunta, A; Magni, C; Antonucci, Fp; De Luca, F; Sarrecchia, C; Bertoli, A; Lenci, I; Francioso, S; Santoro, Mm; Vecchiet, J; Marenco, S; Picciotto, A; Nosotti, L; Morisco, F; Bruno, S; Puoti, M; Babudieri, S; Mura, Ms; Andreoni, M; Rizzardini, G; Parruti, G; Levrero, M; Angelico, M; Perno, Cf; Ceccherini-Silberstein, F
High efficacy of hepatitis C re-treatment strategies after protease inhibitors failure in real-life settings
2016-01-01 Cento, V; Barbaliscia, S; Lenci, I; Ruggiero, T; Masetti, C; Magni, Cf; Micheli, V; Billotti, E; Di Paolo, D; Melis, M; Teti, E; Lambiase, L; Menzaghi, B; Nicolini, La; Marenco, S; Danieli, E; Di Maio, Vc; Aragri, M; Milana, M; Francioso, S; Bertoli, A; Antonucci, F; Esvan, R; Sarmati, L; Sarrecchia, C; Coppola, N; Messina, V; Claar, E; Puoti, M; Ciancio, A; Bonora, S; Babudieri, S; Di Biagio, A; Picciotto, A; Pasquazzi, C; Andreoni, M; Mura, Ms; Taliani, G; Rizzardini, G; Angelico, M; Ceccherini-Silberstein, F; Perno, Cf
A DELAY IN REACHING TIME TO CLINICAL STABLITY FOR HOSPITALISED PATIENTS WITH CAP IS ASSOCIATED WITH FAILURE WITHIN 30 DAYS AFTER HOSPITAL DISCHARGE
2009-01-01 Aliberti, S.; Piffer, F.; Valeria, Betti; Peyrani, P.; Cattaneo, B.; Zanardelli, M.; Salomoni, G.; Blasi, F.; Ramirez, J.
Conversion to extended release tacrolimus in early post lung transplantation period : a pilot study
2018-01-01 Morlacchi, L.; Rossetti, V.; Rosso, L.; Palleschi, A.; Aliberti, S.; Carrinola, R.; Montoli, M.; Nosotti, M.; Tarsia, P.
Timing of previous hospitalizations impacts outcomes in hospitalized patients with CAP
2009-01-01 Ruvolo, L.; Cattaneo, B.; Rossetti, V.; Piffer, F.; Carnevale, C.; Guarize, J.; Katarzyna, Lyskanowska; Aliberti, S.; Tarsia, P.
A multicenter randomised control trial to evealuate CPAP versus conventional oxygen in patients with acute respiratory failure (ARF) due to CAP
2009-01-01 Maraffi, T.; Brambilla, A. M.; Aliberti, S.; Pelosi, P.; Nava, S.; Tarsia, P.; Martinotti, R.; Maffei, A.; Monzani, V.; Rosti, V.; Cosentini, R.
IN CIDENCE, RISK FACTORS AND OUTCOMES OF CARDIOVASCULAR EVENTS IN HOSPITALISED PATIENTS WITH CAP
2009-01-01 Rossetti, V.; Aliberti, S.; Peyrani, P.; Massari, F. M.; Piffer, F.; Castellotti, P.; Ruvolo, L.; Pappalettera, M.; Ramirez, J.; Blasi, F.
STEROIDS ARE NOT ASSOCIATED WITH AN IMPROVEMENT IN CLINICAL OUTCOMES IN HOSPITALISED PATIENTS WITH CAP
2009-01-01 Castellotti, P.; Betti, V.; Giunta, V.; Aliberti, S.; Pappalettera, M.; Tarsia, P.; Peyrani, P.; Ramirez, J.; Blasi, F.
Acute respiratory failure and severe sepsis in cap : different outcomes?
2009-01-01 Torri, A.; Brambilla, A. M.; Aliberti, S.; Piffer, F.; Maraffi, T.; Monzani, V.; Rosti, V.; Cosentini, R.
ARQ 087, an oral pan- fibroblast growth factor receptor (FGFR) inhibitor, in patients (pts) with advanced and/or metastatic intrahepatic cholangiocarcinoma (iCCA)
2016-01-01 Mazzaferro, V. M.; Shaib, W.; Rimassa, L.; Harris, W.; Personeni, N.; El-rayes, B.; Tolcher, A.; Hall, T.; Wang, Y.; Schwartz, B.; Kazakin, J.; Michele, DROZ DIT BUSSET; Cotsoglou, C.; Papadopoulos, K.
Analysis of interstitial lung involvement in a cohort of 100 patients with systemic sclerosis. Prevalence of alveolitis detected by bronchoalveolar lavage and HRCT
2005-01-01 De Santis, M; Bosello, S; Tolusso, B; Pagliari, G; Pistelli, R; Danza, F; Zoli, A; Ferraccioli, G
T and B cells in the skin of systemic sclerosis patients
2007-01-01 Bosello, S; Lama, G; De Santis, M; Spano, C; Tolusso, B; Sica, G; Ferraccioli, G
Bronchoalveolar lavage cell count in systemic sclerosis patients: Correlation with radiological and functional lung worsening
2006-01-01 De Santis, M; Bosello, S; Peluso, G; Tolusso, B; Alivernini, S; Pagliari, G; Danza, F; Ferraccioli, G
Improved endothelium-dependent vasodilation after endothelin receptor blockade in patients with systemic sclerosis
2007-01-01 Peluso, G; Cardillo, C; Bosello, S; Schinzari, F; De Santis, M; Alivernini, S; Zoli, A; Ferraccioli, G
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| KEY PATTERNS OF HBX AND PRE-S1/S2 MUTATIONS ARE INVOLVED IN MECHANISMS UNDERLYING HBV-INDUCED HEPATOCELLULAR CARCINOMA IN VIVO | 1-gen-2012 | Svicher, V; Mirabelli, C; Cento, V; Salpini, R; Di Maio, Vc; Bertoli, A; Alteri, C; Pollicita, M; Gori, C; Micheli, V; Salso, A; Gubertini, G; Trimoulet, P; Fleury, H; Vecchiet, J; Iapadre, N; Barlattani, A; Mari, T; Pasquazzi, C; Sarrechia, C; Ceccherini-Silberstein, F; Andreoni, M; Angelico, M; Perno, Cf | |
| IN THE ERA OF NEW DIRECT ACTING ANTIVIRAL AGENTS HCV SEQUENCING ALLOWS THE MOST ACCURATE SUBTYPE AND GENOTYPE ASSIGNMENT | 1-gen-2016 | Aragri, M; Di Maio, Vc; Di Paolo, D; Cento, V; De Leonardis, F; Gianserra, L; Tontodonati, M; Micheli, V; Landonio, S; Manunta, A; Bertoli, A; Ciotti, M; Antonucci, Fp; Lenci, I; Francioso, S; Nicolini, La; Marenco, S; Teti, E; Lambiase, L; Milana, M; Maida, I; Di Biagio, A; Pellicelli, A; Nosotti, L; Grieco, S; Cacciatore, P; Romagnoli, D; Siciliano, M; D'Ettorre, G; Babudieri, S; Lichtner, M; Gentilucci, Uv; Romano, M; Sarrecchia, C; Grieco, A; Morisco, F; Mastroianni, C; Vecchiet, J; Puoti, M; D'Amico, E; Gasbarrini, A; Bruno, S; Magni, C; Mura, Ms; Taliani, G; Picciotto, A; Rizzardini, G; Andreoni, M; Pasquazzi, C; Parruti, G; Angelico, M; Perno, Cf; Silberstein, Fc | |
| LOW BURDEN OF DRUG-RESISTANT HBV STRAINS IN ANTI-HBV DRUG-EXPERIENCED AND NAIVE PATIENTS | 1-gen-2011 | Salpini, R; Cento, V; Scopelliti, F; Bertoli, A; Gori, C; Micheli, V; Gubertini, G; De Sanctis, Gm; Sarrecchia, C; Andreoni, M; Angelico, M; Svicher, V; Perno, Cf | |
| OVERLAPPING STRUCTURE OF HBV GENOME AND IMMUNE SELECTING PRESSURE ARE THE MAIN DRIVING FORCES FOR HBV EVOLUTION | 1-gen-2011 | Cento, V; Mirabelli, C; Salpini, R; Han, Y; Mercurio, F; Dimonte, S; Beggel, B; Wittkop, L; Fraune, M; Gori, C; Bertoli, A; Micheli, V; Gubertini, G; Longo, R; Romano, S; Visca, M; Gallinaro, V; Marino, N; Mazzotta, F; De Sanctis, Gm; Tremulet, P; Angelico, M; Zhang, Xx; Verheyen, J; Silberstein, Fc; Perno, Cf; Svicher, V | |
| Novel patterns of mutations in HBV reverse transcriptase associated with lamivudine resistance in HBV-HIV-coinfected patients | 1-gen-2009 | Svicher, V; Alteri, C; Cento, V; Gori, C; Salpini, R; Marcuccilli, F; Bertoli, A; Arlotti, M; Puoti, M; Ladisa, N; Rizzardini, G; Ceccherini-Silberstein, F; Monforte, Ad; Perno, Cf | |
| NS3 and NS5A genotypes variants correlate with slow or fast progression of HCV-related disease after liver transplantation: does the viral diversity play really a role on fibrosis progression? | 1-gen-2012 | Lenci, I; Cucchiarelli, S; Di Maio, C; Cento, V; Milano, M; Di Paolo, D; De Luca, F; Tisone, G; Angelico, M; Perno, Cf; Ceccherini-Silberstein, F | |
| CLINICAL RELEVANCE OF NEXT GENERATION SEQUENCING ON BASELINE DETECTION OF MINORITY RESISTANCE ASSOCIATED VARIANTS IN HCV-1 PATIENTS TREATED WITH PROTEASE INHIBITORS | 1-gen-2015 | Armenia, D; Carioti, L; Di Maio, Vc; Bellocchi, Mc; Di Paolo, D; Guerrieri, F; Calvo, L; Cento, V; Tontodonati, M; Micheli, V; De Leonardis, F; Aragri, M; Polilli, E; Manunta, A; Magni, C; Antonucci, Fp; De Luca, F; Sarrecchia, C; Bertoli, A; Lenci, I; Francioso, S; Santoro, Mm; Vecchiet, J; Marenco, S; Picciotto, A; Nosotti, L; Morisco, F; Bruno, S; Puoti, M; Babudieri, S; Mura, Ms; Andreoni, M; Rizzardini, G; Parruti, G; Levrero, M; Angelico, M; Perno, Cf; Ceccherini-Silberstein, F | |
| High efficacy of hepatitis C re-treatment strategies after protease inhibitors failure in real-life settings | 1-gen-2016 | Cento, V; Barbaliscia, S; Lenci, I; Ruggiero, T; Masetti, C; Magni, Cf; Micheli, V; Billotti, E; Di Paolo, D; Melis, M; Teti, E; Lambiase, L; Menzaghi, B; Nicolini, La; Marenco, S; Danieli, E; Di Maio, Vc; Aragri, M; Milana, M; Francioso, S; Bertoli, A; Antonucci, F; Esvan, R; Sarmati, L; Sarrecchia, C; Coppola, N; Messina, V; Claar, E; Puoti, M; Ciancio, A; Bonora, S; Babudieri, S; Di Biagio, A; Picciotto, A; Pasquazzi, C; Andreoni, M; Mura, Ms; Taliani, G; Rizzardini, G; Angelico, M; Ceccherini-Silberstein, F; Perno, Cf | |
| A DELAY IN REACHING TIME TO CLINICAL STABLITY FOR HOSPITALISED PATIENTS WITH CAP IS ASSOCIATED WITH FAILURE WITHIN 30 DAYS AFTER HOSPITAL DISCHARGE | 1-gen-2009 | Aliberti, S.; Piffer, F.; Valeria, Betti; Peyrani, P.; Cattaneo, B.; Zanardelli, M.; Salomoni, G.; Blasi, F.; Ramirez, J. | |
| Conversion to extended release tacrolimus in early post lung transplantation period : a pilot study | 1-gen-2018 | Morlacchi, L.; Rossetti, V.; Rosso, L.; Palleschi, A.; Aliberti, S.; Carrinola, R.; Montoli, M.; Nosotti, M.; Tarsia, P. | |
| Timing of previous hospitalizations impacts outcomes in hospitalized patients with CAP | 1-gen-2009 | Ruvolo, L.; Cattaneo, B.; Rossetti, V.; Piffer, F.; Carnevale, C.; Guarize, J.; Katarzyna, Lyskanowska; Aliberti, S.; Tarsia, P. | |
| A multicenter randomised control trial to evealuate CPAP versus conventional oxygen in patients with acute respiratory failure (ARF) due to CAP | 1-gen-2009 | Maraffi, T.; Brambilla, A. M.; Aliberti, S.; Pelosi, P.; Nava, S.; Tarsia, P.; Martinotti, R.; Maffei, A.; Monzani, V.; Rosti, V.; Cosentini, R. | |
| IN CIDENCE, RISK FACTORS AND OUTCOMES OF CARDIOVASCULAR EVENTS IN HOSPITALISED PATIENTS WITH CAP | 1-gen-2009 | Rossetti, V.; Aliberti, S.; Peyrani, P.; Massari, F. M.; Piffer, F.; Castellotti, P.; Ruvolo, L.; Pappalettera, M.; Ramirez, J.; Blasi, F. | |
| STEROIDS ARE NOT ASSOCIATED WITH AN IMPROVEMENT IN CLINICAL OUTCOMES IN HOSPITALISED PATIENTS WITH CAP | 1-gen-2009 | Castellotti, P.; Betti, V.; Giunta, V.; Aliberti, S.; Pappalettera, M.; Tarsia, P.; Peyrani, P.; Ramirez, J.; Blasi, F. | |
| Acute respiratory failure and severe sepsis in cap : different outcomes? | 1-gen-2009 | Torri, A.; Brambilla, A. M.; Aliberti, S.; Piffer, F.; Maraffi, T.; Monzani, V.; Rosti, V.; Cosentini, R. | |
| ARQ 087, an oral pan- fibroblast growth factor receptor (FGFR) inhibitor, in patients (pts) with advanced and/or metastatic intrahepatic cholangiocarcinoma (iCCA) | 1-gen-2016 | Mazzaferro, V. M.; Shaib, W.; Rimassa, L.; Harris, W.; Personeni, N.; El-rayes, B.; Tolcher, A.; Hall, T.; Wang, Y.; Schwartz, B.; Kazakin, J.; Michele, DROZ DIT BUSSET; Cotsoglou, C.; Papadopoulos, K. | |
| Analysis of interstitial lung involvement in a cohort of 100 patients with systemic sclerosis. Prevalence of alveolitis detected by bronchoalveolar lavage and HRCT | 1-gen-2005 | De Santis, M; Bosello, S; Tolusso, B; Pagliari, G; Pistelli, R; Danza, F; Zoli, A; Ferraccioli, G | |
| T and B cells in the skin of systemic sclerosis patients | 1-gen-2007 | Bosello, S; Lama, G; De Santis, M; Spano, C; Tolusso, B; Sica, G; Ferraccioli, G | |
| Bronchoalveolar lavage cell count in systemic sclerosis patients: Correlation with radiological and functional lung worsening | 1-gen-2006 | De Santis, M; Bosello, S; Peluso, G; Tolusso, B; Alivernini, S; Pagliari, G; Danza, F; Ferraccioli, G | |
| Improved endothelium-dependent vasodilation after endothelin receptor blockade in patients with systemic sclerosis | 1-gen-2007 | Peluso, G; Cardillo, C; Bosello, S; Schinzari, F; De Santis, M; Alivernini, S; Zoli, A; Ferraccioli, G |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile
Scopri
Tipologia
- 1 Contributo su Rivista2184
Data di pubblicazione
- 2020 - 2026115
- 2010 - 20191351
- 2000 - 2009606
- 1990 - 1999111
- 1988 - 19891
Editore
- Nature Publishing Group4
- s.n4
- ICRS3
- Blackwell1
Rivista
- EUROPEAN JOURNAL OF NUCLEAR MEDIC...124
- EUROPEAN UROLOGY. SUPPLEMENTS124
- GASTROENTEROLOGY123
- THE JOURNAL OF UROLOGY111
- DIGESTIVE AND LIVER DISEASE100
- THE JOURNAL OF NUCLEAR MEDICINE80
- ANNALS OF THE RHEUMATIC DISEASES69
- RADIOTHERAPY AND ONCOLOGY59
- ANNALS OF ONCOLOGY57
- JOURNAL OF CLINICAL ONCOLOGY45
Keyword
- Myelodysplastic syndrome8
- Survival4
- biomimetic3
- Mitochondrial ferritin3
- osteochondral3
- Prognosis3
- scaffold3
- Sideroblastic anemia3
- viscosupplementation3
- COLONOSCOPIC SURVEILLANCE2
Lingua
- eng817
- ita28
- und6
Accesso al fulltext
- no fulltext2131
- reserved51
- open2